Carestart

Covid-19 IgM/IgG

Rapid Diagnostic Test for the Detection of SARS-CoV-2 IgM/IgG Ab

ACCESS BIO’S CARESTART™ COVID-19 lgM/lgG

RAPID COVID-19 TESTING TOOL

NOW FDA EMERGENCY USE AUTHORIZED

SARS-CoV-2, A highly contagious novel virus, had severely impacted the U.S. and global healthcare system and economy. A rapid in vitro testing is a key component to identify and mitigate the spread. The CareStart™ Covid 19 IgM/IgG Rapid Diagnostic Test for the Detection of SARS-CoV-2 IgM/IgG Ab provides a fast and easy diagnostic tool for COVID-19 in the limited testing environment.

TEST
PRINCIPLES

The CareStart™ Covid 19 IgM/IgG Rapid Diagnostic Test for the Detection of SARS-CoV-2 IgM/IgG Ab is a lateral flow immunochromatographic assay which can differentiate SARS-CoV-2 Immunoglobin IgM and IgG antibodies in human blood specimens in a single test within 10 minutes.
PROCEDURE

PROCEDURE

STEP 1

Add 10µl of the sample (whole blood, serum, or plasma).

STEP 2

Add 1 drop of Assay Buffer

STEP 3

Read the test results after 10 minutes.
RESULTS INTREPETATION

RESULTS

INTERPRETATION

Covid-19 Positive

Covid-19 Negative

Invalid

ORDER INFORMATION

ORDER

INFORMATION

CAT. NO.

RCHM-02072

PACKAGE UNIT

20 TESTS / KIT

KIT COMPONENT

20 TEST DEVICES
20 ASSAY BUFFER
20 EXTRACTION VIALS AND CAPS
20 SPECIMEN COLLECTION SWABS
1 POSITIVE AND 1 NEGATIVE CONTROL SWABS
1 INSTRUCTIONS FOR USE